Alvocidib (Flavopiridol)
Revision as of 17:26, 25 July 2017 by Warner-admin (talk | contribs) (Text replacement - "Category:Oral chemotherapy" to "Category:Oral medications")
Mechanism of action
Flavonoid alkaloid CDK9 kinase inhibitor
Route: PO
Diseases for which it is used
History of changes in FDA indication
- 4/13/2007: Granted orphan status for treatment of B-cell chronic lymphocytic leukemia (B-CLL) or prolymphocytic leukemia arising from CLL.
- 4/23/2014: Granted orphan designation for the treatment of patients with acute myeloid leukemia (AML)